Overview

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Status:
Terminated
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether standard medications approved for Alzheimer's disease treatment differ in their action on brain functioning and whether any observed brain activity differences as result of treatment are associated with particular patterns of dementia improvement or reduced decline.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
Ortho-McNeil Neurologics, Inc.
Treatments:
Donepezil
Galantamine